Atlas Trials

A Research Study Looking Into the Effect of Semaglutide and NNC0480 0389 on Blood Levels of a Birth Control Pill in Woman After Menopause

Clinical trial NCT05153564 · COMPLETED

Trial details

NCT number
NCT05153564
Sponsor
Novo Nordisk A/S
Status
COMPLETED
Phase
Phase 1
Study type
INTERVENTIONAL
Diabetes Mellitus, Type 2
Start date
2021-12-13
Primary completion
2022-08-13
Enrollment
27

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.